The report "Asia Pacific Surgical Robots Market by Offering (Instruments & Accessories, Robotic Systems [Laparoscopy, Orthopedic], Services), Application (Urological Surgery, Orthopedic Surgery), End User (Hospitals, Specialty Clinics, ASCs) - Forecast to 2031" is projected to reach USD 4.81 billion by 2031 from USD 2.04 billion in 2025, at a CAGR of 15.4% during the forecast period.
Browse 250 market data Tables and 50 Figures spread through 300 Pages and in-depth TOC on "Asia Pacific Surgical Robots Market, by Offering (Instruments & Accessories, Robotic Systems [Laparoscopy, Orthopedic], Services), Application (Urological Surgery, Orthopedic Surgery), End User (Hospitals, Specialty Clinics, ASCs) - Forecast to 2031"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/asia-pacific-surgical-robots-market-168153418.html
The Asia Pacific surgical robots market is expanding at a fast pace due to the growing use of minimally invasive surgical procedures. The development is also backed by the increased awareness of the benefits of these procedures, e.g., shorter hospital stays, quicker recovery, and fewer complications. The rapid growth of healthcare infrastructure and rising healthcare expenditure in most of the big countries like China, India, Japan, and South Korea are allowing hospitals to make investments in advanced robotic systems. On top of that, demographic factors, mostly a large elderly population and increasing incidences of chronic diseases such as cancer, urological disorders, and orthopedic conditions, are the main reasons for the higher surgical volumes in these areas. The adoption is also being paced by the latest technological innovations, such as AI-enabled navigation, better imaging, and the availability of affordable and locally made robotic systems. The growth is being perpetuated by the rise of medical tourism, the increase in surgeon training programs, government initiatives, and the formation of strategic partnerships between global and regional players.
Instruments & accessories accounted for the largest share of the offerings in the Asia Pacific surgical robots market in 2024.
Within the surgical robots market of the Asia Pacific region, the instruments & accessories segment dominates the share of the offering segment. The main reason for this is that they are consumables that are necessary for each robotic procedure and therefore require frequent replacement. In contrast to robotic systems, which are capital investments made only once, there is a recurring demand for items such as robotic instruments, end effectors, staplers, cannulas, vision components, and disposable accessories, as they have limited usage lives. This leads to a steady revenue flow to manufacturers. The increasing number of robotic-assisted surgeries in urology, gynecology, general surgery, and orthopedics in countries like China, Japan, India, and South Korea is driving up the consumption of these products to a great extent. Besides, when hospitals take up a robotic platform, they generally buy a wider range of instruments to be able to support multiple specialties and different types of procedures. This, in turn, facilitates accessory sales to rise even more. The impact of instruments and accessories, which is the most consistent and reliable revenue-generating segment in the Asia–Pacific surgical robots market, is further cemented by the continued introduction of new robotic platforms and the growing surgeon preference for advanced and procedure-specific tools.
The hospitals & specialty clinics segment accounted for the largest share in the Asia Pacific surgical robots market, by end user, in 2024.
The ability of hospitals & specialty clinics to buy high-tech robotic systems and handle complex, high-volume surgical operations has made them account for the biggest share in the end-user segment of the Asia Pacific surgical robots market. As a result, large multispecialty hospitals and advanced clinics are the main procurers of surgical robots since they possess the required infrastructure, trained surgical teams, and financial strength to facilitate the installation, maintenance, and continuous use of instruments in robotics. Moreover, these institutions perform robotic-assisted procedures extensively in general surgery, urology, gynecology, orthopedics, and cardiothoracic applications, thereby leading to higher utilization rates than those in other care settings. Hospitals and clinics are increasingly employing robotic surgery as a unique feature to lure patients, elevate clinical outcomes, and consolidate their prestige of providing advanced care, especially in the medical tourism sectors of countries like India, China, Japan, and South Korea.
In 2024, Japan accounted for the largest share of the Asia Pacific surgical robotsmarket.
The Asia Pacific surgical robots market saw Japan holding the largest portion. This is mainly due to its sophisticated healthcare system, the early integration of medical robotics, and the strong regulatory and reimbursement support for robotic-assisted procedures. With one of the world's fastest-aging populations, Japan has a high demand for surgeries in areas like urology, gastrointestinal surgery, and oncology, where the use of robots can lead to higher precision and better results.
Well-organized surgeon training programs, high levels of acceptance of technology, and reimbursement coverage for certain robotic procedures under the national health insurance system have been some of the factors that have led to the widespread use of surgical robots in hospitals. Together, these factors make Japan the largest and most mature market for surgical robots in the Asia Pacific region.
Key Market Players
The key players in the Asia Pacific surgical robots are Intuitive Surgical (US), Stryker(US), Medtronic (Ireland), Smith+Nephew (UK), and Zimmer Biomet (US), among other players.
About MarketsandMarkets™
MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.
MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.
Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.
The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.
Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.
To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook .
Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit Our Website: https://www.marketsandmarkets.com
